$34.96
-0.45 (-1.27%)
Performance
1D
—
1W
—
1M
—
3M
-10.08%
6M
+146.89%
1Y
+406.67%
YTD
+0.63%
Open$34.77
Previous Close$35.41
Day High$35.14
Day Low$34.05
52W High$43.73
52W Low$3.72
Volume—
Avg Volume1.49M
Market Cap6.22B
P/E Ratio—
EPS$-2.48
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$37.85
Below
SMA 200
$20.09
Above
RSI (14)
53
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
19 analysts
Price Target
+140.2% upside
Current
$34.96
$34.96
Target
$83.97
$83.97
$51.90
$83.97 avg
$108.57
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 1.66B | 1.76B | 1.56B |
| Net Income | -282,006,496 | -354,880,166 | -268,142,716 |
| Profit Margin | -17.0% | -20.2% | -17.2% |
| EBITDA | -474,772,680 | -496,954,417 | -453,512,070 |
| Free Cash Flow | -249,995,996 | -301,722,393 | -268,935,506 |
| Rev Growth | -0.8% | +1.9% | -1.2% |
| Debt/Equity | 0.59 | 0.54 | 0.55 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $205.20 | +0.13% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $348.43 | -0.38% | 24.4 | 188.06B |
| GILD | Gilead Sciences Inc | $138.11 | +0.56% | 20.0 | 170.34B |
| VRTX | Vertex Pharmaceuticals Inc | $448.62 | -0.58% | 29.2 | 115.53B |
| REGN | Regeneron Pharmaceuticals | $741.69 | +0.70% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $308.05 | +0.45% | 139.7 | 43.84B |